Results 201 to 210 of about 843,336 (254)

Laser For complex coronary Artery lesion pReparatiOn: the results of the pilot FARO study. [PDF]

Postepy Kardiol Interwencyjnej
Ambrosini V, Armigliato P, Colombo A, Napodanno M, Golino L.   +4 more
europepmc   +1 more source

Drug-Coated Balloons in All-Comer Population-Are We There Yet? [PDF]

J Clin Med
Lazar FL, Onea HL, Homorodean C, Bitea IC, Lazar DR, Ober MC, Tataru D, Olinic M, Spinu M, Kacso TP, Olinic DM.   +10 more
europepmc   +1 more source

Clinical outcomes of patients with acute myocardial infarction undergoing coronary revascularization via simplified treatment: a single-center retrospective study. [PDF]

World J Emerg Med
Shi Y, Li N, Feng X, Zhang Q, Bao S, Zhao Z, Sun L, Yan S, Wang Y, Li X.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Restenosis following coronary angioplasty

The International Journal of Cardiac Imaging, 1990
The assessment of restenosis following angioplasty has become increasingly important in determining the clinical value of the procedure. Despite this there has been no uniformly accepted methodology for assessing the procedure and consequently the published results have often been misleading with little concensus.
Patrick W. Serruys, Kevin J. Beatt
openaire   +6 more sources

Allergy in coronary in-stent restenosis [PDF]

The Lancet, 2001
Sir—Ralf Koster and colleagues (Dec 2, p 1895) report on nickel and molybdenum contact allergies in patients with coronary restenosis. We have reservations about their study design and the interpretation of their findings. 131 patients presented with suspected restenosis after coronaryartery stenting underwent patch testing for possible metal allergy ...
Akiva Trattner, Daniel Mimouni, Michael David   +2 more
  +8 more sources

Preventing treatment failures in coronary artery disease: what can we learn from the biology of in-stent restenosis, vein graft failure and internal thoracic arteries?

Cardiovascular Research, 2020
Coronary artery disease (CAD) remains one of the most important causes of morbidity and mortality worldwide, and the availability of percutaneous or surgical revascularization procedures significantly improves survival.
C. Spadaccio, C. Antoniades, A. Nenna, Calvin Chung, Ricardo Will, M. Chello, M. Gaudino   +6 more
semanticscholar   +1 more source

Coronary Restenosis

Journal of the American Academy of Nurse Practitioners, 1996
Return of angina within 6 months of a catheter-based treatment of coronary artery disease usually reflects restenosis due to an overly aggressive local healing response to the procedure-related arterial injury. The restenotic lesion should be treated aggressively.
C, Brown, L, Clark, L, Williams, S, Gallagher, M, Levesque, J, Silva   +5 more
openaire   +2 more sources

Prevention of Coronary Restenosis

Cardiology in Review, 1999
Percutaneous transluminal coronary angioplasty (PTCA) was introduced 22 years ago as a nonsurgical catheter-based treatment for obstructive coronary artery disease. Over the following 2 decades, major advances in equipment and techniques led to tremendous growth in the use of PTCA to treat coronary artery disease and angina.
Paul S. Teirstein, Peter J. Casterella
openaire   +3 more sources

Costs of coronary restenosis (Lovastatin Restenosis Trial)

The American Journal of Cardiology, 1996
Within the Lovastatin Restenosis Trial, restenosis has been clearly shown to increase resource utilization and costs. While it is not possible to generalize these results to other patient populations, it is clear that successful efforts to decrease restenosis will certainly improve efficacy while decreasing follow-up costs and increasing the cost ...
J.David Talley, Susan P. Gilbert, William S. Weintraub, Stephen J. Boccuzzi   +3 more
openaire   +3 more sources

Controlled Slow-Release Drug-Eluting Stents for the Prevention of Coronary Restenosis: Recent Progress and Future Prospects.

ACS Applied Materials and Interfaces, 2015
Drug-eluting stents (DES) have become more widely used by cardiologists than bare metal stents (BMS) because of their better ability to control restenosis.
T. Hu, Jiali Yang, Kun Cui, Qiong Rao, T. Yin, Lili Tan, Y. Zhang, Zhenggong Li, Guixue Wang   +8 more
semanticscholar   +1 more source